Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy

Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy

Despite aggressive treatment, the 5-year event-free survival rate for children with high-risk neuroblastoma is <50%. While most high-risk neuroblastoma patients initially respond to treatment, often with complete clinical remission, many eventually relapse with therapy-resistant tumors. Novel the...

Full description

Bibliographic Details
Main Authors: Anders Valind, Bronte Manouk Verhoeven, Jens Enoksson, Jenny Karlsson, Gustav Christensson, Adriana Mañas, Kristina Aaltonen, Caroline Jansson, Daniel Bexell, Ninib Baryawno, David Gisselsson, Catharina Hagerling
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:OncoImmunology
Subjects:
Neuroblastoma
MYCN amplification
macrophages
chemotherapy
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2023.2184130

Similar Items

Similar Items